Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Neoadjuvant Therapy × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Neoplasms 6 Esophageal Squamous Cell Carcinoma 5 Rectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Surgery 1 Stomach Neoplasms 1 Stage III and IV Ovarian Cancer 1 Squamous Cell Carcinoma of External Auditory Canal 1 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Trastuzumab 13 pertuzumab 8 Docetaxel 6 tucatinib 5 pyrotinib 4 Capecitabine 4 Paclitaxel 3 Carboplatin 2 Ado-Trastuzumab Emtansine 2 trastuzumab deruxtecan 1 pegfilgrastim 1 neratinib 1 exemestane 1 dalpiciclib 1 Leuprolide 1 Isovaleryl-CoA Dehydrogenase 1 Injections 1 Goserelin 1 Fulvestrant 1 Fluorodeoxyglucose F18 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡